HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

liptruzet

a combination of ezetimibe and atorvastatin

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrroles: 369
      - liptruzet: 2
  - Azetines
    - Azetidines: 6
      - liptruzet: 2
Pharmaceutical Preparations
- Drug Combinations: 5337
  - liptruzet: 2
Lipids: 114793
- Fatty Acids: 27405
  - Heptanoic Acids
    - liptruzet: 2

Experts

1.	Ahmed, Mohamed H: 1 article (01/2015)
2.	Elmadhoun, Wadie M: 1 article (01/2015)
3.	Hassan, Abdallah Tarig: 1 article (01/2015)
4.	Husain, Nazik Elmalaika: 1 article (01/2015)
5.	Goldenberg, Marvin M: 1 article (07/2013)

Related Diseases

1.	Chronic Obstructive Pulmonary Disease (COPD) 07/01/2013 - "Fluticasone furoate/vilanterol inhalation powder (Breo Ellipta) for chronic obstructive pulmonary disease; atorvastatin/ezetimibe tablets (Liptruzet) for reducing low-density lipoproteincholesterol; and radium 223 dichloride (Xofigo) injection for late-stage, castrationresistant prostate cancer. "
2.	Prostatic Neoplasms (Prostate Cancer) 07/01/2013 - "Fluticasone furoate/vilanterol inhalation powder (Breo Ellipta) for chronic obstructive pulmonary disease; atorvastatin/ezetimibe tablets (Liptruzet) for reducing low-density lipoproteincholesterol; and radium 223 dichloride (Xofigo) injection for late-stage, castrationresistant prostate cancer. "
3.	Hyperlipidemias (Hyperlipidemia) 01/01/2015 - "The combination of ezetimibe and atorvastatin (Liptruzet - referred to in this article as eze/ator), has recently been approved by the FDA for reducing low-density lipoprotein cholesterol (LDL-c) in patients with primary or mixed hyperlipidemia as in case of homozygous familial hypercholesterolemia. "
4.	Homozygous Familial Hypercholesterolemia 01/01/2015 - "The combination of ezetimibe and atorvastatin (Liptruzet - referred to in this article as eze/ator), has recently been approved by the FDA for reducing low-density lipoprotein cholesterol (LDL-c) in patients with primary or mixed hyperlipidemia as in case of homozygous familial hypercholesterolemia. "

Related Drugs and Biologics

1.	Ezetimibe (Zetia)
2.	Atorvastatin (Lipitor)
3.	Tablets
4.	Radium
5.	Powders
6.	LDL Cholesterol
7.	radium Ra 223 dichloride
8.	vilanterol
9.	fluticasone furoate
10.	oxidized low density lipoprotein